{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T05:14:06Z","timestamp":1741324446592,"version":"3.38.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005633","name":"Heart Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005432","name":"North Savo Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005432","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010129","name":"Maud Kuistila Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.lfs.2025.123486","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T07:56:28Z","timestamp":1739951788000},"page":"123486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Heightened sensitivity to adverse effects of metformin in mtDNA mutant patient cells"],"prefix":"10.1016","volume":"366-367","author":[{"given":"Sanna","family":"Ryytty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katriina","family":"Nurminen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petri","family":"M\u00e4kinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anu","family":"Suomalainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riikka H.","family":"H\u00e4m\u00e4l\u00e4inen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2025.123486_bb0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1210\/endrev\/bnaa023","article-title":"Cellular and molecular mechanisms of metformin action","volume":"42","author":"LaMoia","year":"2021","journal-title":"Endocr. Rev."},{"issue":"8","key":"10.1016\/j.lfs.2025.123486_bb0010","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/BF00404340","article-title":"Effect of metformin on insulin-stimulated glucose transport in isolated skeletal muscle obtained from patients with NIDDM","volume":"37","author":"Galuska","year":"1994","journal-title":"Diabetologia"},{"issue":"13","key":"10.1016\/j.lfs.2025.123486_bb0015","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1056\/NEJM199803263381303","article-title":"Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus","volume":"338","author":"Inzucchi","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2025.123486_bb0020","doi-asserted-by":"crossref","first-page":"1022739","DOI":"10.3389\/fgene.2022.1022739","article-title":"Metformin: activation of 5\u2019 AMP-activated protein kinase and its emerging potential beyond anti-hyperglycemic action","volume":"13","author":"Goel","year":"2022","journal-title":"Front. Genet."},{"issue":"8","key":"10.1016\/j.lfs.2025.123486_bb0025","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.lfs.2025.123486_bb0030","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s40620-015-0258-1","article-title":"Metformin modulates apoptosis and cell signaling of human podocytes under high glucose conditions","volume":"29","author":"Langer","year":"2016","journal-title":"J. Nephrol."},{"issue":"2","key":"10.1016\/j.lfs.2025.123486_bb0035","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cmet.2016.12.009","article-title":"Metformin inhibits hepatic mTORC1 signaling via dose-dependent mechanisms involving AMPK and the TSC complex","volume":"25","author":"Howell","year":"2017","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.lfs.2025.123486_bb0040","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000531432","article-title":"Cardiovascular protection by metformin: latest advances in basic and clinical research","volume":"148","author":"Li","year":"2023","journal-title":"Cardiology"},{"key":"10.1016\/j.lfs.2025.123486_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113686","article-title":"Mechanism of metformin regulation in central nervous system: progression and future perspectives","volume":"156","author":"Cao","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"31","key":"10.1016\/j.lfs.2025.123486_bb0050","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.2174\/0929867324666170404143102","article-title":"Update on the protective renal effects of metformin in diabetic nephropathy","volume":"24","author":"Eisenreich","year":"2017","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2025.123486_bb0055","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/s12967-023-04263-8","article-title":"Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing","volume":"21","author":"Hua","year":"2023","journal-title":"J. Transl. Med."},{"issue":"14","key":"10.1016\/j.lfs.2025.123486_bb0060","doi-asserted-by":"crossref","first-page":"R551","DOI":"10.1016\/j.cub.2006.06.054","article-title":"Mitochondria: more than just a powerhouse","volume":"16","author":"McBride","year":"2006","journal-title":"Curr. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123486_bb0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/07853890.2011.598547","article-title":"Mechanisms of mitochondrial diseases","volume":"44","author":"Ylikallio","year":"2012","journal-title":"Ann. Med."},{"issue":"1","key":"10.1016\/j.lfs.2025.123486_bb0070","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00415-015-7884-3","article-title":"Mitochondrial disease: genetics and management","volume":"263","author":"Ng","year":"2016","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.lfs.2025.123486_bb0075","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.24362","article-title":"Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease","volume":"77","author":"Gorman","year":"2015","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.lfs.2025.123486_bb0080","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1086\/301959","article-title":"Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population","volume":"63","author":"Majamaa","year":"1998","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.lfs.2025.123486_bb0085","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.mito.2006.12.004","article-title":"Population prevalence of the MELAS A3243G mutation","volume":"7","author":"Manwaring","year":"2007","journal-title":"Mitochondrion"},{"issue":"2","key":"10.1016\/j.lfs.2025.123486_bb0090","doi-asserted-by":"crossref","first-page":"128","DOI":"10.17712\/nsj.2021.2.20200145","article-title":"The non-syndromic clinical spectrums of mtDNA 3243A>G mutation","volume":"26","author":"Shen","year":"2021","journal-title":"Neurosciences"},{"issue":"9","key":"10.1016\/j.lfs.2025.123486_bb0095","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nrg3966","article-title":"The dynamics of mitochondrial DNA heteroplasmy: implications for human health and disease","volume":"16","author":"Stewart","year":"2015","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"10.1016\/j.lfs.2025.123486_bb0100","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1038\/s41598-019-42262-2","article-title":"Quantitative variation in m.3243A>G mutation produce discrete changes in energy metabolism","volume":"9","author":"McMillan","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.lfs.2025.123486_bb0105","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/07853890510007188","article-title":"Molecular mechanisms of mitochondrial diabetes (MIDD)","volume":"37","author":"Maassen","year":"2005","journal-title":"Ann. Med."},{"issue":"4","key":"10.1016\/j.lfs.2025.123486_bb0110","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1016\/j.ijcard.2013.05.062","article-title":"Defining cardiac adaptations and safety of endurance training in patients with m.3243A>G-related mitochondrial disease","volume":"168","author":"Bates","year":"2013","journal-title":"Int. J. Cardiol."},{"year":"2024","series-title":"Metformin-Associated Lactic Acidosis (MALA)","author":"Dyatlova","key":"10.1016\/j.lfs.2025.123486_bb0115"},{"issue":"8","key":"10.1016\/j.lfs.2025.123486_bb0120","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1097\/CCM.0000000000001002","article-title":"Extracorporeal treatment for metformin poisoning: systematic review and recommendations from the extracorporeal treatments in poisoning workgroup","volume":"43","author":"Calello","year":"2015","journal-title":"Crit. Care Med."},{"issue":"2","key":"10.1016\/j.lfs.2025.123486_bb0125","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cmet.2015.01.003","article-title":"Metformin action: concentrations matter","volume":"21","author":"He","year":"2015","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.lfs.2025.123486_bb0130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","article-title":"Clinical pharmacokinetics of metformin","volume":"50","author":"Graham","year":"2011","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.lfs.2025.123486_bb0135","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.forsciint.2018.03.003","article-title":"Range of therapeutic metformin concentrations in clinical blood samples and comparison to a forensic case with death due to lactic acidosis","volume":"286","author":"Hess","year":"2018","journal-title":"Forensic Sci. Int."},{"issue":"21","key":"10.1016\/j.lfs.2025.123486_bb0140","first-page":"2487","article-title":"Vaikea laktaattiasidoosi","volume":"124","author":"Reinikainen","year":"2008","journal-title":"Duodecim"},{"issue":"16","key":"10.1016\/j.lfs.2025.123486_bb0145","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.3390\/cells11162593","article-title":"Varied responses to a high m.3243A>G mutation load and respiratory chain dysfunction in patient-derived cardiomyocytes","volume":"11","author":"Ryytty","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2025.123486_bb0150","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.trsl.2020.10.002","article-title":"Biphasic effect of metformin on human cardiac energetics","volume":"229","author":"Emelyanova","year":"2021","journal-title":"Translational Research"},{"issue":"38","key":"10.1016\/j.lfs.2025.123486_bb0155","doi-asserted-by":"crossref","first-page":"E3622","DOI":"10.1073\/pnas.1311660110","article-title":"Tissue- and cell-type-specific manifestations of heteroplasmic mtDNA 3243A>G mutation in human induced pluripotent stem cell-derived disease model","volume":"110","author":"H\u00e4m\u00e4l\u00e4inen","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.lfs.2025.123486_bb0160","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s13238-017-0499-y","article-title":"Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs","volume":"9","author":"Yang","year":"2018","journal-title":"Protein Cell"},{"issue":"1","key":"10.1016\/j.lfs.2025.123486_bb0165","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nprot.2012.150","article-title":"Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt\/\u03b2-catenin signaling under fully defined conditions","volume":"8","author":"Lian","year":"2013","journal-title":"Nat. Protoc."},{"issue":"4","key":"10.1016\/j.lfs.2025.123486_bb0170","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"5","key":"10.1016\/j.lfs.2025.123486_bb0175","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.3892\/etm.2016.3143","article-title":"Metformin induces apoptosis via a mitochondria-mediated pathway in human breast cancer cells in vitro","volume":"11","author":"Gao","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.lfs.2025.123486_bb0180","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3389\/fphys.2018.01039","article-title":"Molecular mechanisms of metformin for diabetes and Cancer treatment","volume":"9","author":"Li","year":"2018","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123486_bb0185","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12903-023-02978-0","article-title":"Effects of metformin on human gingival fibroblasts: an in vitro study","volume":"23","author":"Alshibani","year":"2023","journal-title":"BMC Oral Health"},{"key":"10.1016\/j.lfs.2025.123486_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114958","article-title":"Metformin protects fibroblasts from patients with GNE myopathy by restoring autophagic flux via an AMPK\/mTOR-independent pathway","volume":"164","author":"Zhang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.lfs.2025.123486_bb0195","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41574-023-00833-4","article-title":"Metformin: update on mechanisms of action and repurposing potential","volume":"19","author":"Foretz","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123486_bb0200","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11897-023-00592-3","article-title":"Cardiac involvement in mitochondrial disorders","volume":"20","author":"Popoiu","year":"2023","journal-title":"Curr. Heart Fail. Rep."},{"issue":"19","key":"10.1016\/j.lfs.2025.123486_bb0205","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1111\/jcmm.17519","article-title":"Protective effects of metformin in various cardiovascular diseases: clinical evidence and AMPK-dependent mechanisms","volume":"26","author":"Bu","year":"2022","journal-title":"J. Cell. Mol. Med."},{"issue":"5","key":"10.1016\/j.lfs.2025.123486_bb0210","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/hep.23891","article-title":"Polymerase \u03b3 gene POLG determines the risk of sodium valproate-induced liver toxicity","volume":"52","author":"Stewart","year":"2010","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"12","key":"10.1016\/j.lfs.2025.123486_bb0215","article-title":"Patient care standards for primary mitochondrial disease: a consensus statement from the mitochondrial medicine society. Genetics in medicine: official journal of the American College of Medical","volume":"19","author":"Parikh","year":"2017","journal-title":"Genetics"},{"key":"10.1016\/j.lfs.2025.123486_bb0220","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3480607","article-title":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain","volume":"348 Pt 3(Pt 3)","author":"Owen","year":"2000","journal-title":"Biochem. J."},{"issue":"11\u221212","key":"10.1016\/j.lfs.2025.123486_bb0225","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1177\/0885066618793385","article-title":"Review of Biguanide (metformin) toxicity","volume":"34","author":"Wang","year":"2019","journal-title":"J. Intensive Care Med."},{"issue":"9","key":"10.1016\/j.lfs.2025.123486_bb0230","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/s41591-018-0159-7","article-title":"Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase","volume":"24","author":"Hunter","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2025.123486_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.930308","article-title":"Therapeutic vs. suprapharmacological metformin concentrations: different effects on energy metabolism and mitochondrial function in skeletal muscle cells in vitro","volume":"13","author":"Pavlovic","year":"2022","journal-title":"Frontiers in Pharmacology"},{"issue":"4","key":"10.1016\/j.lfs.2025.123486_bb0240","doi-asserted-by":"crossref","first-page":"C1131","DOI":"10.1152\/ajpcell.00186.2023","article-title":"Redox state and altered pyruvate metabolism contribute to a dose-dependent metformin-induced lactate production of human myotubes","volume":"325","author":"Maurer","year":"2023","journal-title":"Am. J. Physiol. Cell Physiol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525001195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525001195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T12:34:12Z","timestamp":1741264452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320525001195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":48,"alternative-id":["S0024320525001195"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123486","relation":{},"ISSN":["0024-3205"],"issn-type":[{"type":"print","value":"0024-3205"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heightened sensitivity to adverse effects of metformin in mtDNA mutant patient cells","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123486","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"123486"}}